Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-01-24 @ 9:22 PM
Study NCT ID:
NCT04838860
Status:
TERMINATED
Last Update Posted:
2021-04-19
First Post:
2021-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Sponsor:
RECORDATI GROUP
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EUSA SYL 0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None